---
title: "SymptoAI: SymptoAI is a digital platform for the early detection and management of diabetes."
url: https://emrr.uz/ndpi
language: en
updated: 2026-11-18T10:22:47Z
source: emrr (https://emrr.uz)
---

# SymptoAI

SymptoAI is a digital platform for the early detection and management of diabetes.

[y.ndpi.uz](https://y.ndpi.uz/)

- **Industry**: HealthTech & MedTech
- **Founded**: 2025
- **Based in**: Republic of Karakalpakstan, Uzbekistan

## Verified revenue: not connected yet

Is SymptoAI yours? Claim this page and connect Stripe, the App Store or Google Play: your MRR and growth show here, read straight from the source.

[Claim it if it’s yours](https://panel.emrr.uz/reserve/ndpi)

## About

SymptoAI is a digital platform for the early detection and management of diabetes. It helps patients complete health assessments, receive reminders, and monitor their health, while enabling healthcare professionals to collect data, generate reports, and improve the efficiency of diabetes diagnosis and prevention.

### The problem

Many people are diagnosed with diabetes too late, do not undergo regular screening, and struggle to manage their condition. Healthcare professionals also lack efficient tools to continuously monitor patients and manage medical data.

### The solution

SymptoAI is an AI-powered platform for the early detection and management of diabetes. It enables patients to complete health assessments, receive reminders, and monitor their health, while helping healthcare professionals collect patient data, generate reports, and improve diagnosis.

## Funding

- **Stage**: Idea

## Pitch deck

The founders’ own deck, for people signed in to emrr.

Profile data from startupbase.uz.

Updated 18 November 2026

[This page in Markdown](https://emrr.uz/ndpi.md)

[Get your verified page](https://emrr.uz/): Connect Stripe, the App Store or Google Play in two minutes and get a page like this one. emrr reads every figure itself, so investors don’t have to take your word for it. Free while MRR is under $1,000.
